{"nct_id":"NCT03785925","title":"A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer","status":"COMPLETED","status_verified_date":"2023-03","start_date":"2019-04-29","start_date_type":"ACTUAL","primary_completion_date":"2022-02-09","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NKTR"]}